» Articles » PMID: 33231535

Development of Rift Valley Fever Encephalitis in Rats is Mediated by Early Infection of Olfactory Epithelium and Neuroinvasion Across the Cribriform Plate

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2020 Nov 24
PMID 33231535
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The zoonotic emerging Rift Valley fever virus (RVFV) causes sporadic disease in livestock and humans throughout Africa and the Saudi Arabian peninsula. Infection of people with RVFV can occur through mosquito bite or mucosal exposure during butchering or milking of infected livestock. Disease typically presents as a self-limiting fever; however, in rare cases, hepatitis, encephalitis and ocular disease may occur. Recent studies have illuminated the neuropathogenic mechanisms of RVFV in a rat aerosol infection model. Neurological disease in rats is characterized by breakdown of the blood-brain barrier late in infection, infiltration of leukocytes to the central nervous system (CNS) and massive viral replication in the brain. However, the route of RVFV entry into the CNS after inhalational exposure remains unknown. Here, we visualized the entire nasal olfactory route from snout to brain after RVFV infection using RNA hybridization and immunofluorescence microscopy. We found widespread RVFV-infected cells within the olfactory epithelium, across the cribriform plate, and in the glomerular region of the olfactory bulb within 2 days of infection. These results indicate that the olfactory tract is a major route of infection of the brain after inhalational exposure. A better understanding of potential neuroinvasion pathways can support the design of more effective therapeutic regiments for the treatment of neurological disease caused by RVFV.

Citing Articles

The Dissemination of Rift Valley Fever Virus to the Eye and Sensory Neurons of Zebrafish Larvae Is Stat1-Dependent.

Ter Horst S, Siekierska A, De Meulemeester A, Cuvry A, Cools L, Neyts J Viruses. 2025; 17(1).

PMID: 39861877 PMC: 11768566. DOI: 10.3390/v17010087.


Comparative study of two Rift Valley fever virus field strains originating from Mauritania.

Chabert M, Lacote S, Marianneau P, Confort M, Aurine N, Pedarrieu A PLoS Negl Trop Dis. 2024; 18(12):e0012728.

PMID: 39652604 PMC: 11658707. DOI: 10.1371/journal.pntd.0012728.


Lrp1 facilitates infection of neurons by Jamestown Canyon virus.

Frey Z, Price D, Connors K, Rush R, Brown G, Sterling C bioRxiv. 2024; .

PMID: 39574651 PMC: 11580904. DOI: 10.1101/2024.11.06.622176.


Rift Valley fever virus is able to cross the human blood-brain barrier by direct infection with no deleterious effects.

Quellec J, Piro-Megy C, Cannac M, Nisole S, Marty F, Gosselet F J Virol. 2024; 98(10):e0126724.

PMID: 39345143 PMC: 11494904. DOI: 10.1128/jvi.01267-24.


Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis.

Connors K, Chapman N, McMillen C, Hoehl R, McGaughey J, Frey Z JCI Insight. 2024; 9(18.

PMID: 39088277 PMC: 11457859. DOI: 10.1172/jci.insight.180151.


References
1.
LaBeaud A, Pfeil S, Muiruri S, Dahir S, Sutherland L, Traylor Z . Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya. PLoS Negl Trop Dis. 2015; 9(3):e0003548. PMC: 4357470. DOI: 10.1371/journal.pntd.0003548. View

2.
McIntosh B, Russell D, Dos Santos I, Gear J . Rift Valley fever in humans in South Africa. S Afr Med J. 1980; 58(20):803-6. View

3.
Caroline A, Powell D, Bethel L, Oury T, Reed D, Hartman A . Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever. PLoS Negl Trop Dis. 2014; 8(4):e2790. PMC: 3983105. DOI: 10.1371/journal.pntd.0002790. View

4.
Abdel-Wahab K, el Baz L, Omar H, Ossman M, YASIN W . Rift Valley Fever virus infections in Egypt: Pathological and virological findings in man. Trans R Soc Trop Med Hyg. 1978; 72(4):392-6. DOI: 10.1016/0035-9203(78)90134-7. View

5.
Wonderlich E, Caroline A, McMillen C, Walters A, Reed D, Barratt-Boyes S . Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis. J Virol. 2017; 92(3). PMC: 5774883. DOI: 10.1128/JVI.01662-17. View